On June 27, 2025, Immunic, Inc. received a notice from Nasdaq due to its common stock's bid price being below $1.00 for 30 consecutive days and has until December 24, 2025, to regain compliance or face potential delisting. The company is evaluating options to meet this requirement, including a possible reverse stock split.